Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 15 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 8, no: 4 |
NetGPI | no | yes: 0, no: 12 |
Related structures:
AlphaFold database: A0A3S7X4C1
Term | Name | Level | Count |
---|---|---|---|
GO:0006629 | lipid metabolic process | 3 | 13 |
GO:0008152 | metabolic process | 1 | 13 |
GO:0044238 | primary metabolic process | 2 | 13 |
GO:0071704 | organic substance metabolic process | 2 | 13 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 7 |
GO:0004806 | triglyceride lipase activity | 5 | 7 |
GO:0016298 | lipase activity | 4 | 7 |
GO:0016787 | hydrolase activity | 2 | 7 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 7 |
GO:0052689 | carboxylic ester hydrolase activity | 4 | 7 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 164 | 168 | PF00656 | 0.197 |
CLV_NRD_NRD_1 | 104 | 106 | PF00675 | 0.318 |
CLV_NRD_NRD_1 | 2 | 4 | PF00675 | 0.399 |
CLV_PCSK_KEX2_1 | 2 | 4 | PF00082 | 0.399 |
CLV_PCSK_SKI1_1 | 172 | 176 | PF00082 | 0.252 |
CLV_PCSK_SKI1_1 | 228 | 232 | PF00082 | 0.394 |
DEG_Nend_UBRbox_1 | 1 | 4 | PF02207 | 0.414 |
DEG_SPOP_SBC_1 | 196 | 200 | PF00917 | 0.266 |
DOC_MAPK_gen_1 | 216 | 225 | PF00069 | 0.447 |
DOC_MIT_MIM_1 | 130 | 138 | PF04212 | 0.252 |
DOC_PP4_FxxP_1 | 152 | 155 | PF00568 | 0.274 |
DOC_USP7_MATH_1 | 12 | 16 | PF00917 | 0.427 |
DOC_USP7_UBL2_3 | 102 | 106 | PF12436 | 0.320 |
LIG_14-3-3_CanoR_1 | 177 | 185 | PF00244 | 0.310 |
LIG_14-3-3_CanoR_1 | 2 | 8 | PF00244 | 0.455 |
LIG_14-3-3_CanoR_1 | 207 | 217 | PF00244 | 0.579 |
LIG_14-3-3_CanoR_1 | 228 | 234 | PF00244 | 0.398 |
LIG_Actin_WH2_2 | 131 | 147 | PF00022 | 0.252 |
LIG_BRCT_BRCA1_1 | 199 | 203 | PF00533 | 0.524 |
LIG_BRCT_BRCA1_2 | 199 | 205 | PF00533 | 0.308 |
LIG_FHA_1 | 107 | 113 | PF00498 | 0.278 |
LIG_FHA_1 | 197 | 203 | PF00498 | 0.281 |
LIG_FHA_1 | 40 | 46 | PF00498 | 0.372 |
LIG_FHA_1 | 50 | 56 | PF00498 | 0.209 |
LIG_LIR_Apic_2 | 151 | 155 | PF02991 | 0.293 |
LIG_LIR_Gen_1 | 109 | 114 | PF02991 | 0.476 |
LIG_LIR_Nem_3 | 109 | 113 | PF02991 | 0.404 |
LIG_LIR_Nem_3 | 192 | 196 | PF02991 | 0.487 |
LIG_LIR_Nem_3 | 88 | 92 | PF02991 | 0.327 |
LIG_PDZ_Class_1 | 229 | 234 | PF00595 | 0.393 |
LIG_PDZ_Wminus1_1 | 232 | 234 | PF00595 | 0.409 |
LIG_PTB_Apo_2 | 156 | 163 | PF02174 | 0.288 |
LIG_PTB_Apo_2 | 80 | 87 | PF02174 | 0.197 |
LIG_PTB_Phospho_1 | 80 | 86 | PF10480 | 0.197 |
LIG_SH2_CRK | 89 | 93 | PF00017 | 0.252 |
LIG_SH2_SRC | 195 | 198 | PF00017 | 0.348 |
LIG_SH2_STAP1 | 110 | 114 | PF00017 | 0.252 |
LIG_SH2_STAP1 | 86 | 90 | PF00017 | 0.295 |
LIG_SH2_STAT5 | 150 | 153 | PF00017 | 0.310 |
LIG_SH2_STAT5 | 195 | 198 | PF00017 | 0.411 |
LIG_SH3_3 | 183 | 189 | PF00018 | 0.299 |
LIG_SUMO_SIM_anti_2 | 183 | 189 | PF11976 | 0.252 |
LIG_WRC_WIRS_1 | 149 | 154 | PF05994 | 0.293 |
MOD_CK1_1 | 208 | 214 | PF00069 | 0.615 |
MOD_CK1_1 | 74 | 80 | PF00069 | 0.369 |
MOD_CK1_1 | 88 | 94 | PF00069 | 0.228 |
MOD_CK2_1 | 195 | 201 | PF00069 | 0.291 |
MOD_CK2_1 | 74 | 80 | PF00069 | 0.453 |
MOD_GlcNHglycan | 10 | 13 | PF01048 | 0.374 |
MOD_GlcNHglycan | 219 | 222 | PF01048 | 0.590 |
MOD_GSK3_1 | 3 | 10 | PF00069 | 0.589 |
MOD_GSK3_1 | 70 | 77 | PF00069 | 0.252 |
MOD_N-GLC_1 | 208 | 213 | PF02516 | 0.568 |
MOD_NEK2_1 | 19 | 24 | PF00069 | 0.417 |
MOD_NEK2_1 | 203 | 208 | PF00069 | 0.502 |
MOD_NEK2_1 | 217 | 222 | PF00069 | 0.408 |
MOD_NEK2_1 | 49 | 54 | PF00069 | 0.318 |
MOD_NEK2_1 | 85 | 90 | PF00069 | 0.333 |
MOD_PIKK_1 | 39 | 45 | PF00454 | 0.442 |
MOD_PKA_2 | 176 | 182 | PF00069 | 0.281 |
MOD_PKA_2 | 49 | 55 | PF00069 | 0.288 |
MOD_Plk_1 | 19 | 25 | PF00069 | 0.457 |
MOD_Plk_4 | 165 | 171 | PF00069 | 0.302 |
MOD_Plk_4 | 54 | 60 | PF00069 | 0.228 |
MOD_Plk_4 | 85 | 91 | PF00069 | 0.281 |
MOD_SUMO_rev_2 | 139 | 147 | PF00179 | 0.252 |
TRG_ENDOCYTIC_2 | 110 | 113 | PF00928 | 0.416 |
TRG_ENDOCYTIC_2 | 89 | 92 | PF00928 | 0.318 |
TRG_ER_diArg_1 | 1 | 3 | PF00400 | 0.436 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0S4IJE8 | Bodo saltans | 33% | 71% |
A0A0S4J5D7 | Bodo saltans | 35% | 75% |
A0A0S4JTA1 | Bodo saltans | 36% | 76% |
A0A1X0NH29 | Trypanosomatidae | 37% | 96% |
A0A1X0NHD7 | Trypanosomatidae | 36% | 100% |
A0A1X0P001 | Trypanosomatidae | 38% | 68% |
A0A3Q8IG97 | Leishmania donovani | 37% | 100% |
A2QSY5 | Aspergillus niger (strain CBS 513.88 / FGSC A1513) | 31% | 83% |
A4HLK7 | Leishmania braziliensis | 46% | 70% |
A4I6H7 | Leishmania infantum | 37% | 100% |
A4I6H8 | Leishmania infantum | 99% | 100% |
B8NIB8 | Aspergillus flavus (strain ATCC 200026 / FGSC A1120 / IAM 13836 / NRRL 3357 / JCM 12722 / SRRC 167) | 35% | 83% |
O42807 | Aspergillus niger | 31% | 83% |
O42815 | Aspergillus tubingensis | 30% | 84% |
O59952 | Thermomyces lanuginosus | 35% | 80% |
P47145 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 26% | 71% |
P61869 | Penicillium cyclopium | 29% | 77% |
P61870 | Penicillium camembertii | 29% | 77% |
Q0CBM7 | Aspergillus terreus (strain NIH 2624 / FGSC A1156) | 33% | 83% |
Q2UNW5 | Aspergillus oryzae (strain ATCC 42149 / RIB 40) | 34% | 83% |
Q4Q6I0 | Leishmania major | 38% | 100% |
Q9BHD5 | Leishmania major | 81% | 100% |
Q9P979 | Aspergillus awamori | 30% | 83% |
Q9XTR8 | Caenorhabditis elegans | 35% | 66% |
V5B761 | Trypanosoma cruzi | 37% | 89% |